Q3 2025 · 13F-HR
B Group, Inc.holdings as filed
Filed 2025-11-14 · accession 0001420506-25-003231
$135.9M
Reported value
20
Positions
2025-09-30
Period end
The Brief · B Group, Inc. · Q3 2025
AI · grounded in 13F
B Group, Inc. established a new position in ADMA valued at $35.4M. The fund also initiated new stakes in LLY for $17.2M and NVDA for $14M. Additional new positions include ZLAB at $13.6M and AKRO at $11M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 000899104 | ADMA | ADMA BIOLOGICS INC | $35.4M | 26.0% | 2,412,542 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $17.2M | 12.6% | 22,500 | PUT | SOLE |
| 67066G104 | NVDA | NVIDIA CORPORATION | $14.0M | 10.3% | 75,000 | PUT | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $13.6M | 9.97% | 400,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $11.0M | 8.12% | 232,446 | Common | SOLE |
| 15117K103 | CLLS | CELLECTIS S A | $9.4M | 6.88% | 3,281,501 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $5.9M | 4.33% | 1,800,556 | Common | SOLE |
| 045396207 | ASMB | ASSEMBLY BIOSCIENCES INC | $4.5M | 3.31% | 175,706 | Common | SOLE |
| 629444118 | NRXPW | NRX PHARMACEUTICALS INC | $4.5M | 3.28% | 3,000,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.1M | 2.99% | 135,000 | Common | SOLE |
| 05153U107 | AURA | AURA BIOSCIENCES INC | $3.5M | 2.60% | 572,576 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $3.3M | 2.39% | 1,500,000 | Common | SOLE |
| 82657M105 | SGHT | SIGHT SCIENCES INC | $3.2M | 2.35% | 930,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $1.7M | 1.23% | 100,000 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $1.7M | 1.23% | 31,500 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $1.4M | 1.06% | 75,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $1.4M | 1.02% | 35,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $209,500 | 0.15% | 50,000 | CALL | SOLE |
| 36468G103 | GAME | GAMESQUARE HLDGS INC | $169,700 | 0.12% | 250,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $22,754 | 0.02% | 158 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.